ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
17.92
-0.08 (-0.44%)
At close: Jul 24, 2025, 4:00 PM
17.60
-0.32 (-1.79%)
After-hours: Jul 24, 2025, 7:21 PM EDT

ARS Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
97.1289.150.031.325.5117.84
Revenue Growth (YoY)
971120.00%297063.33%-97.72%-76.10%-69.13%-
Cost of Revenue
19.3720.5620.2717.1220.2714.07
Gross Profit
77.7568.59-20.24-15.8-14.773.77
Selling, General & Admin
104.8271.6847.2818.664.694.23
Operating Expenses
104.8271.6847.2818.664.694.23
Operating Income
-27.07-3.08-67.52-34.46-19.45-0.47
Interest Expense
-----0.8-0.4
Currency Exchange Gain (Loss)
------0.2
Other Non Operating Income (Expenses)
4.474.126.011.120.010
EBT Excluding Unusual Items
-22.61.03-61.51-33.34-20.24-1.07
Gain (Loss) on Sale of Investments
7.247.256.85-0.29--
Gain (Loss) on Sale of Assets
--0.3---
Pretax Income
-15.368.29-54.37-34.68-20.24-1.07
Income Tax Expense
0.290.29----
Net Income
-15.658-54.37-34.68-20.24-1.07
Net Income to Common
-15.658-54.37-34.68-20.24-1.07
Shares Outstanding (Basic)
979795402920
Shares Outstanding (Diluted)
9710295402920
Shares Change (YoY)
1.62%7.54%138.30%38.39%42.81%-
EPS (Basic)
-0.160.08-0.57-0.87-0.70-0.05
EPS (Diluted)
-0.160.08-0.57-0.87-0.70-0.05
Free Cash Flow
-21.0612.99-59.44-40.28-17.629.07
Free Cash Flow Per Share
-0.220.13-0.62-1.01-0.610.45
Gross Margin
80.06%76.94%---268.20%21.11%
Operating Margin
-27.87%-3.46%-225066.67%-2618.54%-353.32%-2.63%
Profit Margin
-16.11%8.97%-181216.67%-2635.41%-367.65%-5.97%
Free Cash Flow Margin
-21.68%14.57%-198136.67%-3060.56%-319.94%50.86%
EBITDA
-26.72-3-67.45-34.43-19.24-0.46
EBITDA Margin
-27.51%-3.37%----2.60%
D&A For EBITDA
0.350.080.070.030.210.01
EBIT
-27.07-3.08-67.52-34.46-19.45-0.47
EBIT Margin
-27.87%-3.46%----2.63%
Effective Tax Rate
-3.48%----
Revenue as Reported
97.1289.150.03--17.84
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q